France Dialysis Market Projected to Reach USD 7 Billion by 2030, Fueled by Rising Chronic Kidney Disease Prevalence
The France dialysis market, is set to grow at a compound annual growth rate (CAGR) of 3%, reaching USD 7 billion by 2030, according to a recent report by Next Move Strategy Consulting.
Download Your Free Sample Today!
The significant growth in the dialysis market is driven by the increasing prevalence of chronic health conditions such as diabetes and hypertension. These conditions, when unmanaged, often lead to kidney damage and Chronic Kidney Disease (CKD), which necessitates dialysis as a critical treatment solution.
Chronic Kidney Disease, marked by a progressive decline in kidney function, has become increasingly common due to aging populations, lifestyle-related health issues, and early detection resulting from greater healthcare awareness. This rising incidence of CKD in France highlights the growing need for accessible and advanced dialysis treatments, including both hemodialysis and peritoneal dialysis.
As the patient pool expands, healthcare providers and industry stakeholders are focusing on innovation and capacity-building to meet the increasing demand for dialysis services. These advancements are not only improving patient outcomes but also driving significant market growth.
Conclusion
The France dialysis market is poised for steady growth, supported by the surge in diabetes, hypertension, and CKD cases. With an aging population and increased awareness around early diagnosis, the demand for high-quality dialysis services continues to rise. This trend underscores the critical role of innovative dialysis solutions in addressing the healthcare challenges associated with kidney-related complications.